Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 13/20 | 0.80 |
| ▸ | CHRNA3 | P32297 | 11/20 | 0.80 |
| ▸ | CHRNB4 | P30926 | 5/20 | 0.73 |
| ▸ | CHRNB1 | P11230 | 4/20 | 0.73 |
| ▸ | CHRNB3 | Q05901 | 4/20 | 0.73 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.70 |
| ▸ | CHRNA2 | Q15822 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8440172 | 0.99 | CHRNB2 (0.78) | CHRNB2CHRNA3CHRNB4CHRNB1CHRNB3 | |
| SCHEMBL2499296 | 0.89 | CHRNB2 (1.00) | CHRNB2CHRNA3CHRNB4CHRNB1CHRNB3 | |
| SCHEMBL13322054 | 0.89 | CHRNB2 (1.00) | CHRNB2CHRNA3CHRNB4CHRNB1CHRNB3 | |
| SCHEMBL12190816 | 0.88 | CHRNB2 (0.77) | CHRNB2CHRNA3CHRNB4CHRNB1CHRNB3 | |
| SCHEMBL8305152 | 0.88 | CHRNB2 (0.77) | CHRNB2CHRNA3CHRNB4CHRNB1CHRNB3 | |
| SCHEMBL13308403 | 0.85 | CHRNB2 (0.74) | CHRNB2CHRNA3CHRNB4CHRNB1CHRNB3 | |
| SCHEMBL12190815 | 0.85 | CHRNB2 (0.81) | CHRNB2CHRNA3CHRNB4CHRNB1CHRNB3 | |
| SCHEMBL6583018 | 0.85 | CHRNA3 (0.81) | CHRNB2CHRNA3CHRNB4CHRNB1CHRNB3 | |
| SCHEMBL14303745 | 0.84 | CHRNB2 (1.00) | CHRNB2CHRNA3CHRNB4CHRNB1CHRNB3 | |
| SCHEMBL7676161 | 0.84 | CHRNB2 (0.84) | CHRNB2CHRNA3CHRNB4CHRNB1CHRNB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5914328-A | CONTROL DOPAMINE RELEASE, ACTIVATE CHOLINERGIC CHANNELS | ABBOTT LABORATORIES (US) | 1999-06-22 | — | — | US | claimed |
| US-5914328-A | CONTROL DOPAMINE RELEASE, ACTIVATE CHOLINERGIC CHANNELS | ABBOTT LABORATORIES (US) | 1999-06-22 | — | — | US | disclosed |